{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:27:27Z","timestamp":1787059647712,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,19]]},"DOI":"10.7759\/cureus.103895","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T11:20:42Z","timestamp":1771500042000},"source":"Crossref","is-referenced-by-count":1,"title":["Temporalis Muscle Thickness as a Prognostic Factor for 30-Day, 90-Day, and Overall Mortality in Newly Diagnosed Glioblastoma"],"prefix":"10.7759","author":[{"given":"Mohamed","family":"Abouelleil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Nabulsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabah","family":"Hamidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankush","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Massie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Momina","family":"Mustaquim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Macki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Walbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Robin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent","family":"Griffith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilaluddin","family":"Jamaluddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven N","family":"Kalkanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian Y","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hesham M","family":"Zakaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nox158","article-title":"CBTRUS Statistical Report: primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014","volume":"19","author":"Ostrom QT","year":"2017","unstructured":"Ostrom QT, Gittleman H, Liao P, Vecchione-Koval T, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS. CBTRUS Statistical Report: primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014. Neuro Oncol. 2017, 19:v1-v88. 10.1093\/neuonc\/nox158","journal-title":"Neuro Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp R","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, et al.. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005, 352:987-96. 10.1056\/NEJMoa043330","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdad058","article-title":"Suicidal ideation and attempts in brain tumor patients and survivors: a systematic review","volume":"5","author":"Mofatteh M","year":"2023","unstructured":"Mofatteh M, Mashayekhi MS, Arfaie S, et al.. Suicidal ideation and attempts in brain tumor patients and survivors: a systematic review. Neurooncol Adv. 2023, 5:vdad058. 10.1093\/noajnl\/vdad058","journal-title":"Neurooncol Adv"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0207849","article-title":"High correlation of temporal muscle thickness with lumbar skeletal muscle cross-sectional area in patients with brain metastases","volume":"13","author":"Leitner J","year":"2018","unstructured":"Leitner J, Pelster S, Sch\u00f6pf V, et al.. High correlation of temporal muscle thickness with lumbar skeletal muscle cross-sectional area in patients with brain metastases. PLoS One. 2018, 13:e0207849. 10.1371\/journal.pone.0207849","journal-title":"PLoS One"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3171\/2012.9.JNS12504","article-title":"Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article","volume":"117","author":"Bloch O","year":"2012","unstructured":"Bloch O, Han SJ, Cha S, et al.. Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article. J Neurosurg. 2012, 117:1032-8. 10.3171\/2012.9.JNS12504","journal-title":"J Neurosurg"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3171\/2014.7.JNS132449","article-title":"Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma","volume":"121","author":"Grabowski MM","year":"2014","unstructured":"Grabowski MM, Recinos PF, Nowacki AS, Schroeder JL, Angelov L, Barnett GH, Vogelbaum MA. Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma. J Neurosurg. 2014, 121:1115-23. 10.3171\/2014.7.JNS132449","journal-title":"J Neurosurg"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3171\/2015.1.FOCUS14755","article-title":"A practical review of prognostic correlations of molecular biomarkers in glioblastoma","volume":"38","author":"Karsy M","year":"2015","unstructured":"Karsy M, Neil JA, Guan J, Mahan MA, Colman H, Jensen RL. A practical review of prognostic correlations of molecular biomarkers in glioblastoma. Neurosurg Focus. 2015, 38:E4. 10.3171\/2015.1.FOCUS14755","journal-title":"Neurosurg Focus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/8013575","article-title":"Diagnostic and therapeutic biomarkers in glioblastoma: current status and future perspectives","volume":"2017","author":"Szopa W","year":"2017","unstructured":"Szopa W, Burley TA, Kramer-Marek G, Kaspera W. Diagnostic and therapeutic biomarkers in glioblastoma: current status and future perspectives. Biomed Res Int. 2017, 2017:8013575. 10.1155\/2017\/8013575","journal-title":"Biomed Res Int"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043331","article-title":"MGMT gene silencing and benefit from temozolomide in glioblastoma","volume":"352","author":"Hegi ME","year":"2005","unstructured":"Hegi ME, Diserens AC, Gorlia T, et al.. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med. 2005, 352:997-1003. 10.1056\/NEJMoa043331","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068782","article-title":"IDH1\/IDH2 mutations define the prognosis and molecular profiles of patients with gliomas: a meta-analysis","volume":"8","author":"Zou P","year":"2013","unstructured":"Zou P, Xu H, Chen P, Yan Q, Zhao L, Zhao P, Gu A. IDH1\/IDH2 mutations define the prognosis and molecular profiles of patients with gliomas: a meta-analysis. PLoS One. 2013, 8:e68782. 10.1371\/journal.pone.0068782","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7812\/TPP\/08-027","article-title":"Prognostic factors for long-term survival after glioblastoma","volume":"12","author":"Walid MS","year":"2008","unstructured":"Walid MS. Prognostic factors for long-term survival after glioblastoma. Perm J. 2008, 12:45-8. 10.7812\/TPP\/08-027","journal-title":"Perm J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1988.6.2.338","article-title":"The prognostic importance of tumor size in malignant gliomas: a computed tomographic scan study by the Brain Tumor Cooperative Group","volume":"6","author":"Wood JR","year":"1988","unstructured":"Wood JR, Green SB, Shapiro WR. The prognostic importance of tumor size in malignant gliomas: a computed tomographic scan study by the Brain Tumor Cooperative Group. J Clin Oncol. 1988, 6:338-43. 10.1200\/JCO.1988.6.2.338","journal-title":"J Clin Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/56.3.m146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried LP","year":"2001","unstructured":"Fried LP, Tangen CM, Walston J, et al.. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001, 56:M146-56. 10.1093\/gerona\/56.3.m146","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/MAJ.0b013e318256c6aa","article-title":"Frailty syndrome in geriatric medicine","volume":"344","author":"Ruiz M","year":"2012","unstructured":"Ruiz M, Cefalu C, Reske T. Frailty syndrome in geriatric medicine. Am J Med Sci. 2012, 344:395-8. 10.1097\/MAJ.0b013e318256c6aa","journal-title":"Am J Med Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.archger.2015.08.002","article-title":"Frailty syndrome and pre-operative risk evaluation: a systematic review","volume":"61","author":"Buigues C","year":"2015","unstructured":"Buigues C, Juarros-Folgado P, Fern\u00e1ndez-Garrido J, Navarro-Mart\u00ednez R, Cauli O. Frailty syndrome and pre-operative risk evaluation: a systematic review. Arch Gerontol Geriatr. 2015, 61:309-21. 10.1016\/j.archger.2015.08.002","journal-title":"Arch Gerontol Geriatr"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1590\/0103-1104201711517","article-title":"Frailty and surgery","volume":"77","author":"Ngwa VC","year":"2016","unstructured":"Ngwa VC, Kar S. Frailty and surgery. Br J Hosp Med. 2016, 77:102-6. 10.1590\/0103-1104201711517","journal-title":"Br J Hosp Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21406","article-title":"Frailty and cancer: implications for oncology surgery, medical oncology, and radiation oncology","volume":"67","author":"Ethun CG","year":"2017","unstructured":"Ethun CG, Bilen MA, Jani AB, Maithel SK, Ogan K, Master VA. Frailty and cancer: implications for oncology surgery, medical oncology, and radiation oncology. CA Cancer J Clin. 2017, 67:362-77. 10.3322\/caac.21406","journal-title":"CA Cancer J Clin"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2018.08.035","article-title":"Sarcopenia, frailty and their prevention by exercise","volume":"132","author":"Nascimento CM","year":"2019","unstructured":"Nascimento CM, Ingles M, Salvador-Pascual A, Cominetti MR, Gomez-Cabrera MC, Vi\u00f1a J. Sarcopenia, frailty and their prevention by exercise. Free Radic Biol Med. 2019, 132:42-9. 10.1016\/j.freeradbiomed.2018.08.035","journal-title":"Free Radic Biol Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2017.01.006","article-title":"Frailty and sarcopenia: the potential role of an aged immune system","volume":"36","author":"Wilson D","year":"2017","unstructured":"Wilson D, Jackson T, Sapey E, Lord JM. Frailty and sarcopenia: the potential role of an aged immune system. Ageing Res Rev. 2017, 36:1-10. 10.1016\/j.arr.2017.01.006","journal-title":"Ageing Res Rev"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-014-4281-6","article-title":"Sarcopenia is a negative prognostic factor after curative resection of colorectal cancer","volume":"22","author":"Miyamoto Y","year":"2015","unstructured":"Miyamoto Y, Baba Y, Sakamoto Y, et al.. Sarcopenia is a negative prognostic factor after curative resection of colorectal cancer. Ann Surg Oncol. 2015, 22:2663-8. 10.1245\/s10434-014-4281-6","journal-title":"Ann Surg Oncol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-011-1976-9","article-title":"Sarcopenia as a prognostic factor among patients with stage III melanoma","volume":"18","author":"Sabel MS","year":"2011","unstructured":"Sabel MS, Lee J, Cai S, Englesbe MJ, Holcombe S, Wang S. Sarcopenia as a prognostic factor among patients with stage III melanoma. Ann Surg Oncol. 2011, 18:3579-85. 10.1245\/s10434-011-1976-9","journal-title":"Ann Surg Oncol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s11764-012-0234-x","article-title":"Prevalence and prognostic effect of sarcopenia in breast cancer survivors: the HEAL Study","volume":"6","author":"Villase\u00f1or A","year":"2012","unstructured":"Villase\u00f1or A, Ballard-Barbash R, Baumgartner K, Baumgartner R, Bernstein L, McTiernan A, Neuhouser ML. Prevalence and prognostic effect of sarcopenia in breast cancer survivors: the HEAL Study. J Cancer Surviv. 2012, 6:398-406. 10.1007\/s11764-012-0234-x","journal-title":"J Cancer Surviv"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3171\/2016.5.FOCUS16152","article-title":"Application of morphometric analysis to patients with lung cancer metastasis to the spine: a clinical study","volume":"41","author":"Zakaria HM","year":"2016","unstructured":"Zakaria HM, Basheer A, Boyce-Fappiano D, et al.. Application of morphometric analysis to patients with lung cancer metastasis to the spine: a clinical study. Neurosurg Focus. 2016, 41:E12. 10.3171\/2016.5.FOCUS16152","journal-title":"Neurosurg Focus"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.4103\/sni.sni_383_17","article-title":"Morphometrics predicts overall survival in patients with multiple myeloma spine metastasis: A retrospective cohort study","volume":"9","author":"Zakaria HM","year":"2018","unstructured":"Zakaria HM, Elibe E, Macki M, et al.. Morphometrics predicts overall survival in patients with multiple myeloma spine metastasis: A retrospective cohort study. Surg Neurol Int. 2018, 9:172. 10.4103\/sni.sni_383_17","journal-title":"Surg Neurol Int"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.spinee.2018.03.007","article-title":"Application of morphometrics as a predictor for survival in female patients with breast cancer spinal metastasis: a retrospective cohort study","volume":"18","author":"Zakaria HM","year":"2018","unstructured":"Zakaria HM, Massie L, Basheer A, et al.. Application of morphometrics as a predictor for survival in female patients with breast cancer spinal metastasis: a retrospective cohort study. Spine J. 2018, 18:1798-803. 10.1016\/j.spinee.2018.03.007","journal-title":"Spine J"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2018.03.115","article-title":"Application of morphometrics as a predictor for survival in patients with prostate cancer metastasis to the spine","volume":"114","author":"Zakaria HM","year":"2018","unstructured":"Zakaria HM, Massie L, Basheer A, et al.. Application of morphometrics as a predictor for survival in patients with prostate cancer metastasis to the spine. World Neurosurg. 2018, 114:e913-9. 10.1016\/j.wneu.2018.03.115","journal-title":"World Neurosurg"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3171\/2015.7.FOCUS15257","article-title":"Morphometrics as a predictor of perioperative morbidity after lumbar spine surgery","volume":"39","author":"Zakaria HM","year":"2015","unstructured":"Zakaria HM, Schultz L, Mossa-Basha F, Griffith B, Chang V. Morphometrics as a predictor of perioperative morbidity after lumbar spine surgery. Neurosurg Focus. 2015, 39:E5. 10.3171\/2015.7.FOCUS15257","journal-title":"Neurosurg Focus"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2013.07.059","article-title":"Temporalis muscle morphomics: the psoas of the craniofacial skeleton","volume":"186","author":"Ranganathan K","year":"2014","unstructured":"Ranganathan K, Terjimanian M, Lisiecki J, et al.. Temporalis muscle morphomics: the psoas of the craniofacial skeleton. J Surg Res. 2014, 186:246-52. 10.1016\/j.jss.2013.07.059","journal-title":"J Surg Res"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s10143-022-01892-3","article-title":"Temporal muscle thickness as an independent prognostic marker in glioblastoma patients-a systematic review and meta-analysis","volume":"45","author":"Sadhwani N","year":"2022","unstructured":"Sadhwani N, Aggarwal A, Mishra A, Garg K. Temporal muscle thickness as an independent prognostic marker in glioblastoma patients-a systematic review and meta-analysis. Neurosurg Rev. 2022, 45:3619-28. 10.1007\/s10143-022-01892-3","journal-title":"Neurosurg Rev"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000257309.50643.0a","article-title":"Clarification of abc\/2 rule for ICH volume","volume":"38","author":"Newman GC","year":"2007","unstructured":"Newman GC. Clarification of abc\/2 rule for ICH volume. Stroke. 2007, 38:862. 10.1161\/01.STR.0000257309.50643.0a","journal-title":"Stroke"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3934\/Neuroscience.2021025","article-title":"Neurosurgery and artificial intelligence","volume":"8","author":"Mofatteh M","year":"2021","unstructured":"Mofatteh M. Neurosurgery and artificial intelligence. AIMS Neurosci. 2021, 8:477-95. 10.3934\/Neuroscience.2021025","journal-title":"AIMS Neurosci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/274259-temporalis-muscle-thickness-as-a-prognostic-factor-for-30-day-90-day-and-overall-mortality-in-newly-diagnosed-glioblastoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T11:20:42Z","timestamp":1771500042000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/274259-temporalis-muscle-thickness-as-a-prognostic-factor-for-30-day-90-day-and-overall-mortality-in-newly-diagnosed-glioblastoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":31,"URL":"https:\/\/doi.org\/10.7759\/cureus.103895","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,19]]}}}